The minimal important difference of one-minute-sit-to-stand test in subjects with chronic pulmonary aspergillosis.
Journal
Lung India : official organ of Indian Chest Society
ISSN: 0970-2113
Titre abrégé: Lung India
Pays: India
ID NLM: 8405380
Informations de publication
Date de publication:
01 Sep 2024
01 Sep 2024
Historique:
received:
08
04
2024
accepted:
24
05
2024
medline:
1
9
2024
pubmed:
1
9
2024
entrez:
31
8
2024
Statut:
ppublish
Résumé
There is a need for simple functional test to assess treatment response in chronic pulmonary aspergillosis (CPA) in resource-constrained settings. The one-minute-sit-to-stand test (1-min-STS) is one such test. However, the minimal important difference (MID) for 1-min-STS in subjects with CPA remains unknown. Herein, we estimate the MID for 1-min-STS for CPA subjects. We retrospectively reviewed the clinical details of CPA subjects treated with oral azoles for 6 months. We included only subjects who completed the 1-min-STS test at baseline and 6 months. We used the change in VAS (visual analogue scale, for overall improvement) as an external anchor. We used the anchor and the distribution (standard deviation-based) methods to determine the MID estimates. We used the anchor-based method only if there was correlation of 0.3 with the 1-min-STS test. One hundred-eight subjects completed the 1-min-STS test at baseline and 6 months. We did not find significant correlation between the change in VAS for overall improvement (r2 = 0.024, P value = 0.809) and the 1-min-STS test. The MID for the 1-min-STS test was 2 repetitions (range, 1.5-2.8 repetitions). The MID for the 1-min-STS test in subjects with CPA was 2 repetitions. Future studies using a global rating of change scale as an anchor must confirm our findings.
Sections du résumé
BACKGROUND AND OBJECTIVE
OBJECTIVE
There is a need for simple functional test to assess treatment response in chronic pulmonary aspergillosis (CPA) in resource-constrained settings. The one-minute-sit-to-stand test (1-min-STS) is one such test. However, the minimal important difference (MID) for 1-min-STS in subjects with CPA remains unknown. Herein, we estimate the MID for 1-min-STS for CPA subjects.
MATERIALS AND METHODS
METHODS
We retrospectively reviewed the clinical details of CPA subjects treated with oral azoles for 6 months. We included only subjects who completed the 1-min-STS test at baseline and 6 months. We used the change in VAS (visual analogue scale, for overall improvement) as an external anchor. We used the anchor and the distribution (standard deviation-based) methods to determine the MID estimates. We used the anchor-based method only if there was correlation of 0.3 with the 1-min-STS test.
RESULTS
RESULTS
One hundred-eight subjects completed the 1-min-STS test at baseline and 6 months. We did not find significant correlation between the change in VAS for overall improvement (r2 = 0.024, P value = 0.809) and the 1-min-STS test. The MID for the 1-min-STS test was 2 repetitions (range, 1.5-2.8 repetitions).
CONCLUSION
CONCLUSIONS
The MID for the 1-min-STS test in subjects with CPA was 2 repetitions. Future studies using a global rating of change scale as an anchor must confirm our findings.
Identifiants
pubmed: 39215977
doi: 10.4103/lungindia.lungindia_168_24
pii: 01408641-202409000-00004
doi:
Types de publication
Journal Article
Langues
eng
Pagination
353-356Informations de copyright
Copyright © 2024 Copyright: © 2024 Indian Chest Society.
Références
Sehgal IS, Dhooria S, Muthu V, Prasad KT, Agarwal R. An overview of the available treatments for chronic cavitary pulmonary aspergillosis. Expert Rev Respir Med 2020;14:715–27
Sehgal IS, Dhooria S, Prasad KT, Muthu V, Aggarwal AN, Chakrabarti A, et al. Anti-fungal agents in the treatment of chronic pulmonary aspergillosis: Systematic review and a network meta-analysis. Mycoses 2021;64:1053–61
Sehgal IS, Dhooria S, Choudhary H, Aggarwal AN, Garg M, Chakrabarti A, et al. Monitoring treatment response in chronic pulmonary aspergillosis: Role of clinical, spirometric and immunological markers. Clin Microbiol Infect 2019;25:1157.e1–7
Denning DW, Riniotis K, Dobrashian R, Sambatakou H. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: Case series, proposed nomenclature change, and review. Clin Infect Dis 2003;37 Suppl 3:S265–80
Sehgal IS, Arora K, Cornely OA, Salzer HJF, Dhooria S, Prasad KT, et al. Characterization of treatment response outcomes in chronic pulmonary aspergillosis: CPAnet definitions versus the existing criteria. Mycopathologia 2023;188:721–30
Van Braeckel E, Page I, Davidsen JR, Laursen CB, Agarwal R, Alastruey-Izquierdo A, et al. Treatment outcome definitions in chronic pulmonary aspergillosis: A CPAnet consensus statement. Eur Respir J 2022;59:2102950
Butland RJ, Pang J, Gross ER, Woodcock AA, Geddes DM. Two-, six-, and 12-minute walking tests in respiratory disease. Br Med J (Clin Res Ed) 1982;284:1607–8
Solway S, Brooks D, Lacasse Y, Thomas S. A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest 2001;119:256–70
Strassmann A, Steurer-Stey C, Lana KD, Zoller M, Turk AJ, Suter P, et al. Population-based reference values for the 1-min sit-to-stand test. Int J Public Health 2013;58:949–53
Kohlbrenner D, Benden C, Radtke T. The 1-minute sit-to-stand test in lung transplant candidates: An alternative to the 6-minute walk test. Respir Care 2020;65:437–43
Bohannon RW. Sit-to-stand test for measuring performance of lower extremity muscles. Percept Mot Skills 1995;80:163–6
Sehgal IS, Dhooria S, Muthu V, Prasad KT, Aggarwal AN, Chakrabarti A, et al. The minimal important difference of six-minute walk test in subjects with chronic pulmonary aspergillosis treated with six-months of oral itraconazole. Lung India 2023;40:185–7
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet 2007;370:1453–7
Gagnier JJ, Lai J, Mokkink LB, Terwee CB. COSMIN reporting guideline for studies on measurement properties of patient-reported outcome measures. Qual Life Res 2021;30:2197–218
Crook S, Büsching G, Schultz K, Lehbert N, Jelusic D, Keusch S, et al. A multicentre validation of the 1-min sit-to-stand test in patients with COPD. Eur Respir J 2017;49:1601871
Draak THP, de Greef BTA, Faber CG, Merkies ISJ. The minimum clinically important difference: Which direction to take. Eur J Neurol 2019;26:850–5
Sehgal IS, Dhooria S, Muthu V, Prasad KT, Aggarwal AN, Chakrabarti A, et al. The minimal important difference of St. George's respiratory questionnaire in subjects with chronic pulmonary aspergillosis. Med Mycol 2023;myad048. doi: 10.1093/mmy/myad048
doi: 10.1093/mmy/myad048
Agarwal R, Sehgal IS, Muthu V, Dhooria S, Prasad KT, Aggarwal AN, et al. Estimating the clinically important change for Saint George's Respiratory Questionnaire in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol Pract 2022;10:2456–8.e1
Agarwal R, Sehgal I, Muthu V, Dhooria S, Prasad K, Aggarwal A. Estimating the minimal important difference for FEV1 in patients with allergic bronchopulmonary aspergillosis. Eur Respir J 2022;60:2201242
Vaidya T, de Bisschop C, Beaumont M, Ouksel H, Jean V, Dessables F, et al. Is the 1-minute sit-to-stand test a good tool for the evaluation of the impact of pulmonary rehabilitation?Determination of the minimal important difference in COPD. Int J Chron Obstruct Pulmon Dis 2016;11:2609–16
Bohannon RW, Crouch R. 1-Minute sit-to-stand test: Systematic review of procedures, performance, and clinimetric properties. J Cardiopulm Rehabil Prev 2019;39:2–8
Al-Shair K, Atherton GTW, Kennedy D, Powell G, Denning DW, Caress A. Validity and reliability of the St. George's Respiratory Questionnaire in assessing health status in patients with chronic pulmonary aspergillosis. Chest 2013;144:623–31
Denning DW, Cadranel J, Beigelman-Aubry C, Ader F, Chakrabarti A, Blot S, et al. Chronic pulmonary aspergillosis: Rationale and clinical guidelines for diagnosis and management. Eur Respir J 2016;47:45–68